Clinical trial
Aortic Valve Regurgitation Acquired After Left Ventricular Assist Device Implantation: an Outstanding in Vivo Model of Valvular Heart Diseases
NCT03279029 is registered in ClinicalTrials.gov with Assistance Publique Hopitaux De Marseille as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Aortic Valve Regurgitation Acquired After Left Ventricular Assist Device Implantation: an Outstanding in Vivo Model of Valvular Heart Diseases
- Lead sponsor
- Assistance Publique Hopitaux De Marseille
- Phase
- Not applicable
- Overall status
- Suspended
- Start date
- September 14, 2017
- Completion date
- August 8, 2023
- Enrollment
- 15 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aortic valve regurgitation acquired